Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Oct 2026
Up to 91% of patients reached EASI-75 at week 152 in the ARCADIA LTE, with consistent safety and gains in itch and quality of life.
Read Full NewsResidual Asthma Exacerbations on Biologics Vary by Mechanism
Newly announced Phase 4 THRIVE trial results showed most patients who previously had an inadequate response to a CGRP-targeting therapy improved with eptinezumab over 24 weeks.
Catch up on any of the neurology headlines you may have missed in September 2026, compiled into 1 place by the NeurologyLive® team.
Elizabeth Spencer, MD, discusses new data from 3 birth cohorts linking PFAS metabolites tied to maternal IBD to elevated calprotectin in children.
Jordan Axelrad, MD, MPH, discusses first-line IBD therapy selection, sequencing after failure, treat-to-target monitoring, and evaluating new agents
A gastroenterologist explains why IBD symptoms don't always signal a flare, the biomarkers used to confirm inflammation, and counseling patients through Crohn's disease.
ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis
1.
Sports for girls are frequently abandoned due to uniform issues.
2.
November 2023, Medical Bulletin 04/.
3.
Induction Immunotherapy Has Durable Survival Benefit in LACC
4.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
5.
Smartphone App Detects Eye Cancers From Photos
1.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
2.
Exercise Capacity During Cancer Recovery: Clinical Evidence, Mechanisms, and Practical Implications
3.
From Bruises to Blood Clots: Everything You Need to Know about Hematoma
4.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
5.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Importance of Cancer Screening and Early Detection
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
Navigating the Complexities of Ph Negative ALL - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge